
Johnson & Johnson
JNJ 246.31 (0.18%) 0.44
Health Care
Pharmaceuticals
Quality Checklist 6/8
5Y Shares Out Change < 0%
ROIC > 10%
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
Quick Ratio > 1
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $593.58(B)
EV: $620.79(B)
Total Equity: $81.54(B)
Earnings date: Apr-14-2026
P/E: 22.13
Forward P/E: 21.36
P/FCF: 30.11
P/S: 6.29
P/B: 7.27
EPS: $11.1
EPS (fwd): $11.5
FCF/share: $8.2
Revenue/share: $39.1
Book value/share: $33.9
ROIC: 21.7%
ROA: 13.5%
ROE: 33.6%
Debt/Equity: 0.60
Current Ratio: 1.00
Gross margin: 68.1%
Operating margin: 26.2%
Net margin: 28.5%
Dividend/share: $5.1
Div. yield: 2.09%
Growth Estimates
Revenue
CAGR: 5.8%FY+1$100.59(B)
FY+2(+5.3%)$105.94(B)
FY+3(+6.3%)$112.64(B)
FY+4(+5.8%)$119.20(B)
FY+5(+5.9%)$126.23(B)
Net Income
CAGR: 8.4%FY+1$28.09(B)
FY+2(+8.3%)$30.44(B)
FY+3(+8.0%)$32.86(B)
FY+4(+8.2%)$35.57(B)
FY+5(+9.1%)$38.81(B)
EPS
CAGR: 9.3%FY+1$11.53
FY+2(+8.8%)$12.54
FY+3(+8.8%)$13.64
FY+4(+9.4%)$14.92
FY+5(+10.1%)$16.43
FCF per share
CAGR: 9.5%FY+1$10.51
FY+2(+3.5%)$10.88
FY+3(+13.2%)$12.32
FY+4(+14.0%)$14.05
FY+5(+7.6%)$15.12
